Trial
NCT02395783
Therapeutic Effects of Maternal Melatonin Administration on Brain Injury and White Matter Disease
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
—
Condition
Premature Birth
Intervention
Melatonin 10 µg
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-02